{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:09:21Z","timestamp":1767704961810,"version":"3.48.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05317-1","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:41:02Z","timestamp":1761907262000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hormonal factors predisposing to the development of meningiomas in men: a case-control study"],"prefix":"10.1007","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3095-0741","authenticated-orcid":false,"given":"Charles","family":"Berthold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianne","family":"Boudreault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Simonyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette","family":"Fournier-Loiselle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Olivier","family":"Champagne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"issue":"3","key":"5317_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","volume":"99","author":"J Wiemels","year":"2010","unstructured":"Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99(3):307\u2013314","journal-title":"J Neurooncol"},{"issue":"2","key":"5317_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.critrevonc.2008.01.010","volume":"67","author":"C Marosi","year":"2008","unstructured":"Marosi C et al (2008) Meningioma. Crit Rev Oncol Hematol 67(2):153\u2013171","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"5317_CR3","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00701-015-2532-3","volume":"157","author":"AL Bernat","year":"2015","unstructured":"Bernat AL et al (2015) Growth stabilization and regression of meningiomas after discontinuation of cyproterone acetate: a case series of 12 patients. Acta Neurochir (Wien) 157(10):1741\u20131746","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"5317_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00701-019-03848-x","volume":"161","author":"T Passeri","year":"2019","unstructured":"Passeri T et al (2019) Spontaneous regression of meningiomas after interruption of nomegestrol acetate: a series of three patients. Acta Neurochir (Wien) 161(4):761\u2013765","journal-title":"Acta Neurochir (Wien)"},{"issue":"10\u201311","key":"5317_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0039-128X(00)00193-8","volume":"65","author":"MA Blankenstein","year":"2000","unstructured":"Blankenstein MA et al (2000) Occurrence, regulation, and significance of progesterone receptors in human meningioma. Steroids 65(10\u201311):795\u2013800","journal-title":"Steroids"},{"key":"5317_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2407-6-152","volume":"6","author":"B Custer","year":"2006","unstructured":"Custer B et al (2006) Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer 6:152","journal-title":"BMC Cancer"},{"issue":"4","key":"5317_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/00002826-198412000-00016","volume":"7","author":"MA Blankenstein","year":"1984","unstructured":"Blankenstein MA, Blaauw G, Lamberts SW (1984) Progestin and Estrogen receptors in human meningioma. Clin Neuropharmacol 7(4):363\u2013367","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"5317_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00701-018-03782-4","volume":"161","author":"PO Champagne","year":"2019","unstructured":"Champagne PO, Passeri T, Froelich S (2019) Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report. Acta Neurochir (Wien) 161(3):589\u2013592","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"5317_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/01.nrl.0000126588.14216.f3","volume":"10","author":"KJ Drummond","year":"2004","unstructured":"Drummond KJ, Zhu JJ, Black PM (2004) Meningiomas: updating basic science, management, and outcome. Neurologist 10(3):113\u2013130","journal-title":"Neurologist"},{"issue":"11","key":"5317_CR10","first-page":"3904","volume":"7","author":"H Ding","year":"2014","unstructured":"Ding H et al (2014) Risk association of meningiomas with MTHFR C677T and GSTs polymorphisms: a meta-analysis. Int J Clin Exp Med 7(11):3904\u20133914","journal-title":"Int J Clin Exp Med"},{"key":"5317_CR11","doi-asserted-by":"crossref","unstructured":"Sekhoacha M et al (2022) Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules, 27(17)","DOI":"10.3390\/molecules27175730"},{"issue":"6","key":"5317_CR12","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/S0022-5347(01)66696-5","volume":"154","author":"ZN Mo","year":"1995","unstructured":"Mo ZN et al (1995) Early and late long-term effects of vasectomy on serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone levels. J Urol 154(6):2065\u20132069","journal-title":"J Urol"},{"issue":"22","key":"5317_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399402005112","volume":"4","author":"JA Ellis","year":"2002","unstructured":"Ellis JA, Sinclair R, Harrap SB (2002) Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med 4(22):1\u201311","journal-title":"Expert Rev Mol Med"},{"issue":"5","key":"5317_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12032-017-0943-0","volume":"34","author":"PJ Wiechno","year":"2017","unstructured":"Wiechno PJ et al (2017) Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor. Med Oncol 34(5):84","journal-title":"Med Oncol"},{"issue":"5","key":"5317_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2165\/00024677-200504050-00003","volume":"4","author":"E Darby","year":"2005","unstructured":"Darby E, Anawalt BD (2005) Male hypogonadism: an update on diagnosis and treatment. Treat Endocrinol 4(5):293\u2013309","journal-title":"Treat Endocrinol"},{"issue":"2","key":"5317_CR16","first-page":"122","volume":"2","author":"J Rajfer","year":"2000","unstructured":"Rajfer J (2000) Relationship between testosterone and erectile dysfunction. Rev Urol 2(2):122\u2013128","journal-title":"Rev Urol"},{"issue":"1","key":"5317_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1517\/14740338.2013.742885","volume":"12","author":"S Gur","year":"2013","unstructured":"Gur S, Kadowitz PJ, Hellstrom WJ (2013) Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation. Expert Opin Drug Saf 12(1):81\u201390","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"5317_CR18","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.1210\/jc.2002-020518","volume":"87","author":"N Pitteloud","year":"2002","unstructured":"Pitteloud N et al (2002) Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 87(9):4128\u20134136","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"5317_CR19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1210\/jcem-41-4-777","volume":"41","author":"B Stripp","year":"1975","unstructured":"Stripp B et al (1975) Effect of spironolactone on sex hormones in man. J Clin Endocrinol Metab 41(4):777\u2013781","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"5317_CR20","first-page":"vdz046","volume":"1","author":"L Giraldi","year":"2019","unstructured":"Giraldi L et al (2019) Male hormone-interfering drugs and meningioma development. Neurooncol Adv 1(1):vdz046","journal-title":"Neurooncol Adv"},{"issue":"3","key":"5317_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.21037\/tau-22-690","volume":"12","author":"B Chislett","year":"2023","unstructured":"Chislett B et al (2023) 5-alpha reductase inhibitors use in prostatic disease and beyond. Transl Androl Urol 12(3):487\u2013496","journal-title":"Transl Androl Urol"},{"key":"5317_CR22","unstructured":"Tadi. B (2024) Inhibitors. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK555930\/"},{"issue":"4","key":"5317_CR23","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3171\/2013.12.JNS131170","volume":"120","author":"JM Schildkraut","year":"2014","unstructured":"Schildkraut JM et al (2014) Endogenous and exogenous hormone exposure and the risk of meningioma in men. J Neurosurg 120(4):820\u2013826","journal-title":"J Neurosurg"},{"issue":"9","key":"5317_CR24","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1111\/ene.15423","volume":"29","author":"L Hoisnard","year":"2022","unstructured":"Hoisnard L et al (2022) Risk of intracranial meningioma with three potent progestogens: A population-based case-control study. Eur J Neurol 29(9):2801\u20132809","journal-title":"Eur J Neurol"},{"issue":"2","key":"5317_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/jnnp-2021-326138","volume":"93","author":"AP Mikkelsen","year":"2022","unstructured":"Mikkelsen AP et al (2022) Cyproterone acetate and risk of meningioma: a nationwide cohort study. J Neurol Neurosurg Psychiatry 93(2):222\u2013223","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"5317_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1365-2125.2011.04031.x","volume":"72","author":"M Gil","year":"2011","unstructured":"Gil M et al (2011) Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study. Br J Clin Pharmacol 72(6):965\u2013968","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"5317_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.canep.2011.08.003","volume":"36","author":"L Cea-Soriano","year":"2012","unstructured":"Cea-Soriano L et al (2012) Hormonal therapies and meningioma: is there a link? Cancer Epidemiol 36(2):198\u2013205","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"5317_CR28","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/fcp.12806","volume":"36","author":"M Yelehe","year":"2022","unstructured":"Yelehe M et al (2022) Adverse effects of gender-affirming hormonal therapy in transgender persons: assessing reports in the French pharmacovigilance database. Fundam Clin Pharmacol 36(6):1115\u20131124","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"5317_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/epirev\/mxw003","volume":"39","author":"H Braun","year":"2017","unstructured":"Braun H et al (2017) Cancer in transgender people: evidence and methodological considerations. Epidemiol Rev 39(1):93\u2013107","journal-title":"Epidemiol Rev"},{"issue":"6","key":"5317_CR30","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/cen.13835","volume":"89","author":"T McFarlane","year":"2018","unstructured":"McFarlane T, Zajac JD, Cheung AS (2018) Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals\u2014A systematic review. Clin Endocrinol 89(6):700\u2013711","journal-title":"Clin Endocrinol"},{"issue":"7","key":"5317_CR31","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awy108","volume":"141","author":"NM Nota","year":"2018","unstructured":"Nota NM et al (2018) The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment. Brain 141(7):2047\u20132054","journal-title":"Brain"},{"issue":"6","key":"5317_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1089\/trgh.2021.0025","volume":"7","author":"CP Millward","year":"2022","unstructured":"Millward CP et al (2022) Development and growth of intracranial meningiomas in transgender women taking cyproterone acetate as Gender-Affirming progestogen therapy: A systematic review. Transgender Health 7(6):473\u2013483","journal-title":"Transgender Health"},{"key":"5317_CR33","doi-asserted-by":"publisher","first-page":"n37","DOI":"10.1136\/bmj.n37","volume":"372","author":"A Weill","year":"2021","unstructured":"Weill A et al (2021) Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study. BMJ 372:n37","journal-title":"BMJ"},{"key":"5317_CR34","doi-asserted-by":"crossref","unstructured":"Aghi MK et al (2007) Increased prevalence of obesity and obesity-related postoperative complications in male patients with meningiomas. Neurosurgery, 61(4):754\u2009\u2013\u200960; discussion 760-1.","DOI":"10.1227\/01.NEU.0000298903.63635.E3"},{"issue":"6","key":"5317_CR35","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1158\/1055-9965.EPI-11-1059","volume":"21","author":"EB Claus","year":"2012","unstructured":"Claus EB et al (2012) Cigarette smoking and risk of meningioma: the effect of gender. Cancer Epidemiol Biomarkers Prev 21(6):943\u2013950","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05317-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05317-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05317-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:34:29Z","timestamp":1767702869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05317-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5317"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05317-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The questionnaire and methodology for this study were approved by the Human Research Ethics committee of\n                      Universit\u00e9 Laval\n                      (Ethics approval number: 2021\u20135746).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}